Pharmaceutical Executive July 28, 2025
New technology has the potential to improve trial design and patient recruitment.
Gen Li, president and founder of Phesi, spoke with Pharmaceutical Executive about issues pharma companies are having during Phase III trials and how new technologies can solve these issues.
Pharmaceutical Executive: What’s causing so many Phase three trials to head for avoidable failure?
Gen Li: The challenges can be put into two different categories. The first is: how good are we designing trial protocols? The problems that we’re seeing can be caused by a mismatch in the design and the patient population being targeted. In those cases, the trial protocol must be amended. The consequence of that is that this causes a delay and prolongs to trial time, which...
Today's Sponsors
Today's Sponsor